Equine arteritis virus

Veterinary Microbiology

Volumn 167, Issue 1-2, 2013, Pages 93-122

  Balasuriya, Udeni B R ^a   Go, Yun Young ^a,c   MacLachlan, N James ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

EAV; Equine arteritis virus; EVA

Indexed keywords

ANTIVIRUS AGENT; CYSTEINE PROTEINASE; E PROTEIN; EXONUCLEASE; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 2; GLYCOPROTEIN GP 3; GLYCOPROTEIN GP 4; GLYCOPROTEIN GP 5; M PROTEIN; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 10; NONSTRUCTURAL PROTEIN 11; NONSTRUCTURAL PROTEIN 12; NONSTRUCTURAL PROTEIN 2; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4; NONSTRUCTURAL PROTEIN 5; NONSTRUCTURAL PROTEIN 6; NONSTRUCTURAL PROTEIN 7ALPHA; NONSTRUCTURAL PROTEIN 8; NONSTRUCTURAL PROTEIN 9; NUCLEOCAPSID PROTEIN; PAPAIN LIKE CYSTEINE PROTEASE; RNA DIRECTED RNA POLYMERASE; STRUCTURAL PROTEIN; TNONSTRUCTURAL PROTEIN 7BETA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; AMINO TERMINAL SEQUENCE; ARTICLE; BACTERIAL DISEASE IMMUNOFLUORESCENCE ASSAY; CARBOXY TERMINAL SEQUENCE; CELLULAR IMMUNITY; DIAGNOSTIC ACCURACY; EQUINE VIRAL ARTERITIS; EQUINE VIRAL ARTERITIS VIRUS; FLOW CYTOMETRY; GENETIC MANIPULATION; GENETIC VARIABILITY; GENOME ANALYSIS; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFECTION SENSITIVITY; INNATE IMMUNITY; LIFE CYCLE; MARE; MOLECULAR CLONING; MOLECULAR EPIDEMIOLOGY; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STALLION; VACCINATION; VIRION; VIRUS CELL INTERACTION; VIRUS DIAGNOSIS; VIRUS ENTRY; VIRUS GENOME; VIRUS ISOLATION; VIRUS MORPHOLOGY; VIRUS NEUTRALIZATION; VIRUS PARTICLE; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TRANSCRIPTION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

EQUIDAE; EQUINE ARTERITIS VIRUS;

EAV; EQUINE ARTERITIS VIRUS; EVA;

ANIMALS; ARTERITIS VIRUS, EQUINE; ARTERIVIRUS INFECTIONS; GENOME, VIRAL; HORSE DISEASES; HORSES; HOST-PATHOGEN INTERACTIONS; VIRAL PROTEINS; VIRION;

EID: 84889089738     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2013.06.015     Document Type: Article

References (288)

1. Abes S., Moulton H.M., Clair P., Prevot P., Youngblood D.S., Wu R.P., Iversen P.L., Lebleu B. Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents. J. Control. Release 2006, 116:304-313.
2. Anonymous NAHMS. Equine Viral Arteritis (EVA) and the U.S. Horse Industry 2000, USDA-APHIS, VS, CEAH, National Animal Health Monitoring System, Fort Collins, CO.
3. Anonymous 2.5.10. Equine viral arteritis. OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (Mammals, Birds and Bees) 2012.
4. Anonymous Equine Arteritis Virus cELISA Correlates Well with SN 2012, Press Release, Inc.
5. Archambault D., St-Laurent G. Induction of apoptosis by equine arteritis virus infection. Virus Genes 2000, 20:143-147.
6. Balasuriya U.B., Dobbe J.C., Heidner H.W., Smalley V.L., Navarrette A., Snijder E.J., MacLachlan N.J. Characterization of the neutralization determinants of equine arteritis virus using recombinant chimeric viruses and site-specific mutagenesis of an infectious cDNA clone. Virology 2004, 321:235-246.
7. Balasuriya U.B., Evermann J.F., Hedges J.F., McKeirnan A.J., Mitten J.Q., Beyer J.C., McCollum W.H., Timoney P.J., MacLachlan N.J. Serologic and molecular characterization of an abortigenic strain of equine arteritis virus isolated from infective frozen semen and an aborted equine fetus. J. Am. Vet. Med. Assoc. 1998, 213:1586-1589.
8. Balasuriya U.B., Hedges J.F., MacLachlan N.J. Molecular epidemiology and evolution of equine arteritis virus. Adv. Exp. Med. Biol. 2001, 494:19-24.
9. Balasuriya U.B., Hedges J.F., Nadler S.A., McCollum W.H., Timoney P.J., MacLachlan N.J. Genetic stability of equine arteritis virus during horizontal and vertical transmission in an outbreak of equine viral arteritis. J. Gen. Virol. 1999, 80(Pt 8):1949-1958.
10. Balasuriya U.B., Hedges J.F., Smalley V.L., Navarrette A., McCollum W.H., Timoney P.J., Snijder E.J., MacLachlan N.J. Genetic characterization of equine arteritis virus during persistent infection of stallions. J. Gen. Virol. 2004, 85:379-390.
11. Balasuriya U.B., Heidner H.W., Davis N.L., Wagner H.M., Hullinger P.J., Hedges J.F., Williams J.C., Johnston R.E., David Wilson W., Liu I.K., James MacLachlan N. Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horses. Vaccine 2002, 20:1609-1617.
12. Balasuriya U.B., Heidner H.W., Hedges J.F., Williams J.C., Davis N.L., Johnston R.E., MacLachlan N.J. Expression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles. J. Virol. 2000, 74:10623-10630.
13. Balasuriya U.B., Leutenegger C.M., Topol J.B., McCollum W.H., Timoney P.J., MacLachlan N.J. Detection of equine arteritis virus by real-time TaqMan reverse transcription-PCR assay. J. Virol. Methods 2002, 101:21-28.
14. Balasuriya U.B., Maclachlan N.J. The immune response to equine arteritis virus: potential lessons for other arteriviruses. Vet. Immunol. Immunopathol. 2004, 102:107-129.
15. Balasuriya U.B., Maclachlan N.J., De Vries A.A., Rossitto P.V., Rottier P.J. Identification of a neutralization site in the major envelope glycoprotein (GL) of equine arteritis virus. Virology 1995, 207:518-527.
16. Balasuriya U.B., Patton J.F., Rossitto P.V., Timoney P.J., McCollum W.H., MacLachlan N.J. Neutralization determinants of laboratory strains and field isolates of equine arteritis virus: identification of four neutralization sites in the amino-terminal ectodomain of the G(L) envelope glycoprotein. Virology 1997, 232:114-128.
17. Balasuriya U.B., Rossitto P.V., DeMaula C.D., MacLachlan N.J. A 29K envelope glycoprotein of equine arteritis virus expresses neutralization determinants recognized by murine monoclonal antibodies. J. Gen. Virol. 1993, 74(Pt 11):2525-2529.
18. Balasuriya U.B., Snijder E.J. Arterivirus. Animal Viruses: Molecular Biology 2008, 97-148. Caister Academic Press, Norwich, United Kingdom. T.C. Mettenleiter, F. Sobrino (Eds.).
19. Balasuriya U.B., Snijder E.J., Heidner H.W., Zhang J., Zevenhoven-Dobbe J.C., Boone J.D., McCollum W.H., Timoney P.J., MacLachlan N.J. Development and characterization of an infectious cDNA clone of the virulent Bucyrus strain of Equine arteritis virus. J. Gen. Virol. 2007, 88:918-924.
20. Balasuriya U.B., Snijder E.J., van Dinten L.C., Heidner H.W., Wilson W.D., Hedges J.F., Hullinger P.J., MacLachlan N.J. Equine arteritis virus derived from an infectious cDNA clone is attenuated and genetically stable in infected stallions. Virology 1999, 260:201-208.
21. Balasuriya U.B., Timoney P.J., McCollum W.H., MacLachlan N.J. Phylogenetic analysis of open reading frame 5 of field isolates of equine arteritis virus and identification of conserved and nonconserved regions in the GL envelope glycoprotein. Virology 1995, 214:690-697.
22. Balasuriya U.B.R., Dobbeb J.C., Heidner H.W., Snijder E.J., MacLachlan N.J. Characterization of the virulence determinants of equine arteritis virus using an infectious cDNA clone derived from the virulent Bucyrus strain. Xth International Nidovirus Symposium 2005.
23. Barrette-Ng I.H., Ng K.K., Mark B.L., Van Aken D., Cherney M.M., Garen C., Kolodenko Y., Gorbalenya A.E., Snijder E.J., James M.N. Structure of arterivirus nsp4. The smallest chymotrypsin-like proteinase with an alpha/beta C-terminal extension and alternate conformations of the oxyanion hole. J. Biol. Chem. 2002, 277:39960-39966.
24. Beerens N., Selisko B., Ricagno S., Imbert I., van der Zanden L., Snijder E.J., Canard B. De novo initiation of RNA synthesis by the arterivirus RNA-dependent RNA polymerase. J. Virol. 2007, 81:8384-8395.
25. Beerens N., Snijder E.J. RNA signals in the 3' terminus of the genome of equine arteritis virus are required for viral RNA synthesis. J. Gen. Virol. 2006, 87:1977-1983.
26. Bell S.A., Balasuriya U.B.R., MacLachlan N.J. Equine viral arteritis. Clin. Tech. Equine Pract. 2006, 5:233-238.
27. Beura L.K., Sarkar S.N., Kwon B., Subramaniam S., Jones C., Pattnaik A.K., Osorio F.A. Porcine reproductive and respiratory syndrome virus nonstructural protein 1beta modulates host innate immune response by antagonizing IRF3 activation. J. Virol. 2010, 84:1574-1584.
28. Beura L.K., Subramaniam S., Vu H.L., Kwon B., Pattnaik A.K., Osorio F.A. Identification of amino acid residues important for anti-IFN activity of porcine reproductive and respiratory syndrome virus non-structural protein 1. Virology 2012, 433:431-439.
29. Bishop S.P. Animal models of vasculitis. Toxicol. Pathol. 1989, 17:109-117.
30. Breese S.S., McCollum W.H. Electron microscopic characterization of equine arteritis virus. 2nd International Conference on Equine Infectious Diseases 1970.
31. Broaddus C.C., Balasuriya U.B., Timoney P.J., White J.L., Makloski C., Torrisi K., Payton M., Holyoak G.R. Infection of embryos following insemination of donor mares with equine arteritis virus infective semen. Theriogenology 2011, 76:47-60.
32. Broaddus C.C., Balasuriya U.B., White J.L., Timoney P.J., Funk R.A., Holyoak G.R. Evaluation of the safety of vaccinating mares against equine viral arteritis during mid or late gestation or during the immediate postpartum period. J. Am. Med. Assoc. 2011, 38(6):741-750.
33. Bryans J.T., Crowe M.E., Doll E.R., McCollum W.H. Isolation of a filterable agent causing arteritis of horses and abortion by mares; its differentiation from the equine abortion (influenza) virus. Cornell Vet. 1957, 47:3-41.
34. Burki F., Hofer A., Nowotny N. Objective data plead to suspend import-bans for seroreactors against equine arteritis virus except for breeder stallions. J. Appl. Anim. Res. 1992, 1:31-42.
35. L: induction of virus-neutralizing antibody and assessment of protection in ponies. J. Gen. Virol. 2001, 82:2425-2435.
36. Castillo-Olivares J., Wieringa R., Bakonyi T., de Vries A.A., Davis-Poynter N.J., Rottier P.J. Generation of a candidate live marker vaccine for equine arteritis virus by deletion of the major virus neutralization domain. J. Virol. 2003, 77:8470-8480.
37. Cavanagh D. Nidovirales: a new order comprising Coronaviridae and Arteriviridae. Arch. Virol. 1997, 142:629-633.
38. Chirnside E.D., Cook R.F., Lock M.W., Mumford J.A. Monoclonal antibodies to equine arteritis virus. The Fifth International Conference of Equine Infectious Diseases 1988, 262-267.
39. Chirnside E.D., de Vries A.A., Mumford J.A., Rottier P.J. Equine arteritis virus-neutralizing antibody in the horse is induced by a determinant on the large envelope glycoprotein GL. J. Gen. Virol. 1995, 76(Pt 8):1989-1998.
40. Chirnside E.D., Francis P.M., de Vries A.A., Sinclair R., Mumford J.A. Development and evaluation of an ELISA using recombinant fusion protein to detect the presence of host antibody to equine arteritis virus. J. Virol. Methods 1995, 54:1-13.
41. Chirnside E.D., Francis P.M., Mumford J.A. Expression cloning and antigenic analysis of the nucleocapsid protein of equine arteritis virus. Virus Res. 1995, 39:277-288.
42. Chirnside E.D., Spaan W.J. Reverse transcription and cDNA amplification by the polymerase chain reaction of equine arteritis virus (EAV). J. Virol. Methods 1990, 30:133-140.
43. Chirnside E.D., Wearing C.M., Binns M.M., Mumford J.A. Comparison of M and N gene sequences distinguishes variation amongst equine arteritis virus isolates. J. Gen. Virol. 1994, 75(Pt 6):1491-1497.
44. Cholleti H., Paidikondala M., Munir M., Hakhverdyan M., Baule C. Equine arteritis virus induced cell death is associated with activation of the intrinsic apoptotic signalling pathway. Virus Res. 2013, 171:222-226.
45. Chowdhary B.P., Paria N., Raudsepp T. Potential applications of equine genomics in dissecting diseases and fertility. Anim. Reprod. Sci. 2008, 107:208-218.
46. Coignoul F.L., Cheville N.F. Pathology of maternal genital tract, placenta, and fetus in equine viral arteritis. Vet. Pathol. 1984, 21:333-340.
47. Cole J.R., Hall R.F., Gosser H.S., Hendricks J.B., Pursell A.R., Senne D.A., Pearson J.E., Gipson C.A. Transmissibility and abortogenic effect of equine viral arteritis in mares. J. Am. Vet. Med. Assoc. 1986, 189:769-771.
48. Collins J.K., Kari S., Ralston S.L., Bennet D.G., Traub-Dargatz J.L., McKinnon A.O. Equine viral arteritis in a veterianry teaching hospital. Prev. Vet. Med. 1987, 4:389-397.
49. Cook R.F., Gann S.J., Mumford J.A. The effects of vaccination with tissue culture-derived viral vaccines on detection of antibodies to equine arteritis virus by enzyme-linked immunosorbent assay (ELISA). Vet. Microbiol. 1989, 20:181-189.
50. Das P.B., Vu H.L., Dinh P.X., Cooney J.L., Kwon B., Osorio F.A., Pattnaik A.K. Glycosylation of minor envelope glycoproteins of porcine reproductive and respiratory syndrome virus in infectious virus recovery, receptor interaction, and immune response. Virology 2011, 410:385-394.
51. Davila S., Hibberd M.L. Genome-wide association studies are coming for human infectious diseases. Genome Med. 2009, 1:19.
52. de Vries A.A., Chirnside E.D., Bredenbeek P.J., Gravestein L.A., Horzinek M.C., Spaan W.J. All subgenomic mRNAs of equine arteritis virus contain a common leader sequence. Nucleic Acids Res. 1990, 18:3241-3247.
53. de Vries A.A., Chirnside E.D., Horzinek M.C., Rottier P.J. Structural proteins of equine arteritis virus. J. Virol. 1992, 66:6294-6303.
54. de Vries A.A., Glaser A.L., Raamsman M.J., de Haan C.A., Sarnataro S., Godeke G.J., Rottier P.J. Genetic manipulation of equine arteritis virus using full-length cDNA clones: separation of overlapping genes and expression of a foreign epitope. Virology 2000, 270:84-97.
55. de Vries A.A., Post S.M., Raamsman M.J., Horzinek M.C., Rottier P.J. The two major envelope proteins of equine arteritis virus associate into disulfide-linked heterodimers. J. Virol. 1995, 69:4668-4674.
56. de Vries A.A., Raamsman M.J., van Dijk H.A., Horzinek M.C., Rottier P.J. The small envelope glycoprotein (GS) of equine arteritis virus folds into three distinct monomers and a disulfide-linked dimer. J. Virol. 1995, 69:3441-3448.
57. de Vries A.A.F., Horzinek M.C., Rottier P.J.M., de Groot R.J. The genome organization of the Nidovirales: similarities and differences between arteri-, toro-, and coronaviruses. Semin. Virol. 1997, 8:33-47.
58. Del Piero F. Diagnosis of equine arteritis virus infection in two horses by using monoclonal antibody immunoperoxidase histochemistry on skin biopsies. Vet. Pathol. 2000, 37:486-487.
59. Del Piero F. Equine viral arteritis. Vet. Pathol. 2000, 37:287-296.
60. den Boon J.A., Faaberg K.S., Meulenberg J.J., Wassenaar A.L., Plagemann P.G., Gorbalenya A.E., Snijder E.J. Processing and evolution of the N-terminal region of the arterivirus replicase ORF1a protein: identification of two papainlike cysteine proteases. J. Virol. 1995, 69:4500-4505.
61. den Boon J.A., Kleijnen M.F., Spaan W.J., Snijder E.J. Equine arteritis virus subgenomic mRNA synthesis: analysis of leader-body junctions and replicative-form RNAs. J. Virol. 1996, 70:4291-4298.
62. den Boon J.A., Snijder E.J., Chirnside E.D., de Vries A.A., Horzinek M.C., Spaan W.J. Equine arteritis virus is not a togavirus but belongs to the coronavirus-like superfamily. J. Virol. 1991, 65:2910-2920.
63. Deregt D., de Vries A.A., Raamsman M.J., Elmgren L.D., Rottier P.J. Monoclonal antibodies to equine arteritis virus proteins identify the GL protein as a target for virus neutralization. J. Gen. Virol. 1994, 75(Pt 9):2439-2444.
64. Deshpande A., Wang S., Walsh M.A., Dokland T. Structure of the equine arteritis virus nucleocapsid protein reveals a dimer-dimer arrangement. Acta Crystallogr. D: Biol. Crystallogr. 2007, 63:581-586.
65. Dobbe J.C., van der Meer Y., Spaan W.J., Snijder E.J. Construction of chimeric arteriviruses reveals that the ectodomain of the major glycoprotein is not the main determinant of equine arteritis virus tropism in cell culture. Virology 2001, 288:283-294.
66. Dokland T. The structural biology of PRRSV. Virus Res. 2010, 154:86-97.
67. Doll E.R., Bryans J.T., McCollum W.H., Crowe M.E. Isolation of a filterable agent causing arteritis of horses and abortion by mares; its differentiation from the equine abortion (influenza) virus. Cornell Vet. 1957, 47:3-41.
68. Doll E.R., Bryans J.T., Wilson J.C., McCollum W.H. Immunization against equine viral arteritis using modified live virus propagated in cell cultures of rabbit kidney. Cornell Vet. 1968, 48:497-524.
69. Doll E.R., Knappenberger R.E., Bryans J.T. An outbreak of abortion caused by the equine arteritis virus. Cornell Vet. 1957, 47:69-75.
70. Duan X., Nauwynck H.J., Pensaert M.B. Effects of origin and state of differentiation and activation of monocytes/macrophages on their susceptibility to porcine reproductive and respiratory syndrome virus (PRRSV). Arch. Virol. 1997, 142:2483-2497.
71. Dunowska M., Biggs P.J., Zheng T., Perrott M.R. Identification of a novel nidovirus associated with a neurological disease of the Australian brushtail possum (Trichosurus vulpecula). Vet. Microbiol. 2012, 156:418-424.
72. Duthie S., Mills H., Burr P. The efficacy of a commercial ELISA as an alternative to virus neutralisation test for the detection of antibodies to EAV. Equine Vet. J. 2008, 40:182-183.
73. Echeverria M.G., Pecoraro M.R., Galosi C.M., Etcheverrigaray M.E., Nosetto E.O. The first isolation of equine arteritis virus in Argentina. Rev. Sci. Tech. 2003, 22:1029-1033.
74. Eichhorn W., Heilmann M., Kaaden O.R. Equine viral arteritis with abortions: serological and virological evidence in Germany. Z. Veterinarmed. B 1995, 42:573-576.
75. Estes P.C., Cheville N.F. The ultrastructure of vascular lesions in equine viral arteritis. Am. J. Pathol. 1970, 58:235-253.
76. Fang Y., Fang L., Wang Y., Lei Y., Luo R., Wang D., Chen H., Xiao S. Porcine reproductive and respiratory syndrome virus nonstructural protein 2 contributes to NF-kappaB activation. Virol. J. 2012, 9:83.
77. Fang Y., Snijder E.J. The PRRSV replicase: exploring the multifunctionality of an intriguing set of nonstructural proteins. Virus Res. 2010, 154:61-76.
78. Firth A.E., Zevenhoven-Dobbe J.C., Wills N.M., Go Y.Y., Balasuriya U.B., Atkins J.F., Snijder E.J., Posthuma C.C. Discovery of a small arterivirus gene that overlaps the GP5 coding sequence and is important for virus production. J. Gen. Virol. 2011, 92:1097-1106.
79. Fukunaga Y., Imagawa H., Tabuchi E., Akiyama Y. Clinical and virological findings on experimental equine viral arteritis in horses. Bull. Equine Res. Inst. 1981, 18:110-118.
80. Fukunaga Y., McCollum W.H. Complement-fixation reactions in equine viral arteritis. Am. J. Vet. Res. 1977, 38:2043-2046.
81. Fukunaga Y., Wada R., Hirasawa K., Kamada M., Kumanomido T., Akiyama Y. Effect of the modified Bucyrus strain of equine arteritis virus experimentally inoculated into horses. Bull. Equine Res. Inst. 1982, 19:97-101.
82. Fukunaga Y., Wada R., Kanemaru T., Imagawa H., Kamada M., Samejima T. Immune potency of lyophilized, killed vaccine for equine viral arteritis and its protection against abortion in pregnant mares. J. Equine Vet. Sci. 1996, 16:217-221.
83. Fukunaga Y., Wada R., Kanemaru T., Imagawa H., Kamada M., Samejima T., Nakajima H., Plowright W. Protection against abortion in pregnant mares vaccinated with killed vaccine after exposure to equine arteritis virus. 7th International Conference of Equine Infectious Diseases 1994, 340.
84. Fukunaga Y., Wada R., Matsumura T., Sugiura T., Imagawa H. Induction of immune response and protection from equine viral arteritis (EVA) by formalin inactivated-virus vaccine for EVA in horses. Z. Veterinarmed. B 1990, 37:135-141.
85. Fukunaga Y., Wada R., Matsumura T., Sugiura T., Imagawa H. An attempt to protect against persistent infection of equine viral arteritis in the reproductive tract of stallions using formalin inactivated-virus vaccine. Sixth International Conference on Equine Infectious Diseases 1991, 239-244.
86. Gallie D.R. A tale of two termini: a functional interaction between the termini of an mRNA is a prerequisite for efficient translation initiation. Gene 1998, 216:1-11.
87. Giese M., Bahr U., Jakob N.J., Kehm R., Handermann M., Muller H., Vahlenkamp T.H., Spiess C., Schneider T.H., Schusse G., Darai G. Stable and long-lasting immune response in horses after DNA vaccination against equine arteritis virus. Virus Genes 2002, 25:159-167.
88. Gilbert S.A., Timoney P.J., McCollum W.H., Deregt D. Detection of equine arteritis virus in the semen of carrier stallions by using a sensitive nested PCR assay. J. Clin. Microbiol. 1997, 35:2181-2183.
89. Glaser A.L., de Vries A.A., Dubovi E.J. Comparison of equine arteritis virus isolates using neutralizing monoclonal antibodies and identification of sequence changes in GL associated with neutralization resistance. J. Gen. Virol. 1995, 76(Pt 9):2223-2233.
90. Glaser A.L., de Vries A.A., Raamsman M.J., Horzinek M.C., Rottier P.J.M. An infectious cDNA clone of equine arteritis virus: a tool for future fundamental studies and vaccine development. The Eight International Conference on Equine Infectious Diseases 1998, 166-176. R&W Publications, Newmarket, UK. U. Wernery, J.F. Wade, J.A. Mumford, O.R. Kaaden (Eds.).
91. Glaser A.L., de Vries A.A., Rottier P.J., Horzinek M.C., Colenbrander B. Equine arteritis virus: a review of clinical features and management aspects. Vet. Q. 1996, 18:95-99.
92. Glaser A.L., de Vries A.A., Rottier P.J., Horzinek M.C., Colenbrander B. Equine arteritis virus: clinical symptoms and prevention. Tijdschr. Diergeneeskd. 1997, 122:2-7.
93. Go Y.Y. Molecular and Genomic Approaches to Understanding Host-Virus Interactions in Shaping the Outcome of Equine Arteritis Virus Infection 2011, University of Kentucky, Lexington.
94. + T cell susceptibility/resistance to equine arteritis virus infection. J. Virol. 2011, 85:13174-13184.
95. + T lymphocytes to equine arteritis virus infection reflects genetic predisposition of naturally infected stallions to become carriers of the virus. J. Virol. 2012.
96. Go Y.Y., Cook R.F., Fulgencio J.Q., Campos J.R., Henney P., Timoney P.J., Horohov D.W., Balasuriya U.B. Assessment of correlation between in vitro CD3(+) T cell susceptibility to EAV infection and clinical outcome following experimental infection. Vet. Microbiol. 2011.
97. Go Y.Y., Snijder E.J., Timoney P.J., Balasuriya U.B. Characterization of equine humoral antibody response to the nonstructural proteins of equine arteritis virus. Clin. Vaccine Immunol. 2011, 18:268-279.
98. Go Y.Y., Wong S.J., Branscum A., Demarset V.L., Shuck K.M., Vickers M.L., Zhang J., McCollum W.H., Timoney P.J., Balasuriya U.B.R. Development of a Fluorescent Microsphere Immunoassay for Detection of Antibodies Specific to Equine Arteritis Virus and Comparison with the Virus Neutralization Test. Clin. Vaccine Immunol. 2007, 15:12.
99. Go Y.Y., Zhang J., Timoney P.J., Cook R.F., Horohov D.W., Balasuriya U.B. Complex interactions between the major and minor envelope proteins of equine arteritis virus determine its tropism for equine CD3+ T lymphocytes and CD14+ monocytes. J. Virol. 2010, 84:4898-4911.
100. Gorbalenya A.E., Blinov V.M., Donchenko A.P., Koonin E.V. An NTP-binding motif is the most conserved sequence in a highly diverged monophyletic group of proteins involved in positive strand RNA viral replication. J. Mol. Evol. 1989, 28:256-268.
101. Gorbalenya A.E., Enjuanes L., Ziebuhr J., Snijder E.J. Nidovirales: evolving the largest RNA virus genome. Virus Res. 2006, 117:17-37.
102. Gorbalenya A.E., Koonin E.V. Viral proteins containing the purine NTP-binding sequence pattern. Nucleic Acids Res. 1989, 17:8413-8440.
103. Gorbalenya A.E., Koonin E.V., Donchenko A.P., Blinov V.M. A novel superfamily of nucleoside triphosphate-binding motif containing proteins which are probably involved in duplex unwinding in DNA and RNA replication and recombination. FEBS Lett. 1988, 235:16-24.
104. Gorbalenya A.E., Koonin E.V., Donchenko A.P., Blinov V.M. Coronavirus genome: prediction of putative functional domains in the non-structural polyprotein by comparative amino acid sequence analysis. Nucleic Acids Res. 1989, 17:4847-4861.
105. Gorbalenya A.E., Koonin E.V., Lai M.M. Putative papain-related thiol proteases of positive-strand RNA viruses. Identification of rubi- and aphthovirus proteases and delineation of a novel conserved domain associated with proteases of rubi-, alpha- and coronaviruses. FEBS Lett. 1991, 288:201-205.
106. Gosert R., Kanjanahaluethai A., Egger D., Bienz K., Baker S.C. RNA replication of mouse hepatitis virus takes place at double-membrane vesicles. J. Virol. 2002, 76:3697-3708.
107. Guthrie A.J., Howell P.G., Hedges J.F., Bosman A.M., Balasuriya U.B., McCollum W.H., Timoney P.J., MacLachlan N.J. Lateral transmission of equine arteritis virus among Lipizzaner stallions in South Africa. Equine Vet. J. 2003, 35:596-600.
108. Hedges J.F., Balasuriya U.B., Ahmad S., Timoney P.J., McCollum W.H., Yilma T., MacLachlan N.J. Detection of antibodies to equine arteritis virus by enzyme linked immunosorbant assays utilizing GL M and N proteins expressed from recombinant baculoviruses. J. Virol. Methods 1998, 76:127-137.
109. Hedges J.F., Balasuriya U.B., MacLachlan N.J. The open reading frame 3 of equine arteritis virus encodes an immunogenic glycosylated, integral membrane protein. Virology 1999, 264:92-98.
110. Hedges J.F., Balasuriya U.B., Timoney P.J., McCollum W.H., MacLachlan N.J. Genetic variation in open reading frame 2 of field isolates and laboratory strains of equine arteritis virus. Virus Res. 1996, 42:41-52.
111. Hedges J.F., Balasuriya U.B., Timoney P.J., McCollum W.H., MacLachlan N.J. Genetic divergence with emergence of novel phenotypic variants of equine arteritis virus during persistent infection of stallions. J. Virol. 1999, 73:3672-3681.
112. Hedges J.F., Balasuriya U.B., Topol J.B., Lee D.W., MacLachlan N.J. Genetic variation of ORFs 3 and 4 of equine arteritis virus. Adv. Exp. Med. Biol. 2001, 494:69-72.
113. Heinrich A., Riethmuller D., Gloger M., Schusser G.F., Giese M., Ulbert S. RNA interference protects horse cells in vitro from infection with Equine Arteritis Virus. Antiviral Res. 2009, 81:209-216.
114. Henson J.B., Crawford T.B. The pathogenesis of virus-induced arterial disease - Aleutian disease and equine viral arteritis. Adv. Cardiol. 1974, 13:183-191.
115. Hill A.V. Aspects of genetic susceptibility to human infectious diseases. Annu. Rev. Genet. 2006, 40:469-486.
116. Holyoak G.R., Little T.V., Vernon M., McCollum W.H., Timoney P.J. Correlation between ultrasonographic findings and serum testosterone concentration in prepubertal and peripubertal colts. Am. J. Vet. Res. 1994, 55:450-457.
117. Hornyak A., Denes B., Szeredi L., Dencso L., Rusvai M. Diagnostic application of immunoperoxidase monolayer assay using monoclonal antibodies produced against equine arteritis virus 14-kDa nucleocapsid protein. Hybrid. Hybridomics 2004, 23:368-372.
118. Hornyak A., Bakonyi T., Tekes G., Szeredi L., Rusvai M. A novel subgroup among genotypes of equine arteritis virus: genetic comparison of 40 strains. J. Vet. Med. B Infect. Dis. Vet. Public Health 2005, 52:112-118.
119. Horzinek M., Maess J., Laufs R. Studies on the substructure of togaviruses. II. Analysis of equine arteritis, rubella, bovine viral diarrhea, and hog cholera viruses. Arch. Gesamte Virusforsch. 1971, 33:306-318.
120. Hullinger P.J., Gardner I.A., Hietala S.K., Ferraro G.L., MacLachlan N.J. Seroprevalence of antibodies against equine arteritis virus in horses residing in the United States and imported horses. J. Am. Vet. Med. Assoc. 2001, 219:946-949.
121. Hullinger P.J., Wilson W.D., Rossitto P.V., Patton J.F., Thurmond M.C., MacLachlan N.J. Passive transfer, rate of decay, and protein specificity of antibodies against equine arteritis virus in horses from a Standardbred herd with high seroprevalence. J. Am. Vet. Med. Assoc. 1998, 213:839-842.
122. Hyllseth B. A plaque assay of equine arteritis virus in BHK-21 cells. Arch. Gesamte Virusforsch. 1969, 28:26-33.
123. Ivanov K.A., Hertzig T., Rozanov M., Bayer S., Thiel V., Gorbalenya A.E., Ziebuhr J. Major genetic marker of nidoviruses encodes a replicative endoribonuclease. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:12694-12699.
124. Jeronimo C., Archambault D. Importance of M-protein C terminus as substrate antigen for serodetection of equine arteritis virus infection. Clin. Diagn. Lab. Immunol. 2002, 9:698-703.
125. Johnson C.R., Griggs T.F., Gnanandarajah J., Murtaugh M.P. Novel structural protein in porcine reproductive and respiratory syndrome virus encoded by an alternative ORF5 present in all arteriviruses. J. Gen. Virol. 2011, 92:1107-1116.
126. Jung K., Renukaradhya G.J., Alekseev K.P., Fang Y., Tang Y., Saif L.J. Porcine reproductive and respiratory syndrome virus modifies innate immunity and alters disease outcome in pigs subsequently infected with porcine respiratory coronavirus: implications for respiratory viral co-infections. J. Gen. Virol. 2009, 90:2713-2723.
127. Kabatek A.a.V.M. Folding and oligomerization of the gp2b/gp3/gp4 spike proteins of equine arteritis virus in vitro. Viruses 2013, 4:10.
128. Kheyar A., Martin S., St-Laurent G., Timoney P.J., McCollum W.H., Archambault D. Expression cloning and humoral immune response to the nucleocapsid and membrane proteins of equine arteritis virus. Clin. Diagn. Lab. Immunol. 1997, 4:648-652.
129. Kim H.S., Kwang J., Yoon I.J., Joo H.S., Frey M.L. Enhanced replication of porcine reproductive and respiratory syndrome (PRRS) virus in a homogeneous subpopulation of MA-104 cell line. Arch. Virol. 1993, 133:477-483.
130. Knoops K., Barcena M., Limpens R.W., Koster A.J., Mommaas A.M., Snijder E.J. Ultrastructural characterization of arterivirus replication structures: reshaping the endoplasmic reticulum to accommodate viral RNA synthesis. J. Virol. 2012, 86:2474-2487.
131. Knoops K., Kikkert M., Worm S.H., Zevenhoven-Dobbe J.C., van der Meer Y., Koster A.J., Mommaas A.M., Snijder E.J. SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum. PLoS Biol. 2008, 6:e226.
132. Kondo T., Fukunaga Y., Sekiguchi K., Sugiura T., Imagawa H. Enzyme-linked immunosorbent assay for serological survey of equine arteritis virus in racehorses. J. Vet. Med. Sci. 1998, 60:1043-1045.
133. Konishi S., Akashi H., Sentsui H., Ogata M. Studies on equine viral arteritis. I. Characterization of the virus and trial survey on antibody with Vero cell cultures. Nihon Juigaku Zasshi 1975, 37:259-267.
134. Laity J.H., Lee B.M., Wright P.E. Zinc finger proteins: new insights into structural and functional diversity. Curr. Opin. Struct. Biol. 2001, 11:39-46.
135. Lauber C., Ziebuhr J., Junglen S., Drosten C., Zirkel F., Nga P.T., Morita K., Snijder E.J., Gorbalenya A.E. Mesoniviridae: a proposed new family in the order Nidovirales formed by a single species of mosquito-borne viruses. Arch. Virol. 2012, 157:1623-1628.
136. Lauck M., Hyeroba D., Tumukunde A., Weny G., Lank S.M., Chapman C.A., O'Connor D.H., Friedrich T.C., Goldberg T.L. Novel, divergent simian hemorrhagic fever viruses in a wild Ugandan red colobus monkey discovered using direct pyrosequencing. PLoS ONE 2011, 6:e19056.
137. Lauck M., Sibley S.D., Hyeroba D., Tumukunde A., Weny G., Chapman C.A., Ting N., Switzer W.M., Kuhn J.H., Friedrich T.C., O'Connor D.H., Goldberg T.L. Exceptional simian hemorrhagic fever virus diversity in a wild African primate community. J. Virol. 2013, 87:688-691.
138. Lawson S.R., Rossow K.D., Collins J.E., Benfield D.A., Rowland R.R. Porcine reproductive and respiratory syndrome virus infection of gnotobiotic pigs: sites of virus replication and co-localization with MAC-387 staining at 21 days post-infection. Virus Res. 1997, 51:105-113.
139. Lee C., Yoo D. The small envelope protein of porcine reproductive and respiratory syndrome virus possesses ion channel protein-like properties. Virology 2006, 355:30-43.
140. Little T.V., Holyoak G.R., McCollum W.H., Timoney P.J. Output of equine arteritis virus from persistently infected stallions is testosterone dependent. Proceedings of the 6th international conference on equine infectious diseases 1991, 225-229.
141. Lopez J.W., del Piero F., Glaser A., Finazzi M. Immunoperoxidase histochemistry as a diagnostic tool for detection of equine arteritis virus antigen in formalin fixed tissues. Equine Vet. J. 1996, 28:77-79.
142. Lu Z., Branscum A.J., Shuck K.M., Zhang J., Dubovi E.J., Timoney P.J., Balasuriya U.B. Comparison of two real-time reverse transcription polymerase chain reaction assays for the detection of Equine arteritis virus nucleic acid in equine semen and tissue culture fluid. J. Vet. Diagn. Invest. 2008, 20:147-155.
143. Lu Z., Zhang J., Huang C.M., Go Y.Y., Faaberg K.S., Rowland R.R., Timoney P.J., Balasuriya U.B. Chimeric viruses containing the N-terminal ectodomains of GP5 and M proteins of porcine reproductive and respiratory syndrome virus do not change the cellular tropism of equine arteritis virus. Virology 2012, 432:99-109.
144. MacLachlan N.J., Balasuriya U.B. Equine viral arteritis. Adv. Exp. Med. Biol. 2006, 581:429-433.
145. MacLachlan N.J., Balasuriya U.B., Hedges J.F., Schweidler T.M., McCollum W.H., Timoney P.J., Hullinger P.J., Patton J.F. Serologic response of horses to the structural proteins of equine arteritis virus. J. Vet. Diagn. Invest. 1998, 10:229-236.
146. MacLachlan N.J., Balasuriya U.B., Rossitto P.V., Hullinger P.A., Patton J.F., Wilson W.D. Fatal experimental equine arteritis virus infection of a pregnant mare: immunohistochemical staining of viral antigens. J. Vet. Diagn. Invest. 1996, 8:367-374.
147. MacLachlan N.J., Conley A.J., Kennedy P.C. Bluetongue and equine viral arteritis viruses as models of virus-induced fetal injury and abortion. Anim. Reprod. Sci. 2000, 60-61:643-651.
148. Maess J., Reczko E., Bohm H.O. Equine arteritis virus: multiplication in BHK 21-cells buoyant density and electron microscopical demonstration. Arch. Gesamte Virusforsch. 1970, 30:47-58.
149. Magnusson P., Hyllseth B., Marusyk H. Morphological studies on equine arteritis virus. Arch. Gesamte Virusforsch. 1970, 30:105-112.
150. Manolaridis I., Gaudin C., Posthuma C.C., Zevenhoven-Dobbe J.C., Imbert I., Canard B., Kelly G., Tucker P.A., Conte M.R., Snijder E.J. Structure and genetic analysis of the arterivirus nonstructural protein 7alpha. J. Virol. 2011, 85:7449-7453.
151. McCollum W.H. Development of a modified virus strain and vaccine for equine viral arteritis. J. Am. Vet. Med. Assoc. 1969, 155:318-322.
152. McCollum W.H. Vaccination for equine viral arteritis. Proceedings of the Second International Conference on Equine Infectious Diseases 1970, 143-151.
153. McCollum W.H. Studies of passive immunity in foals to equine viral arteritis. Vet. Microbiol. 1976, 1:45-54.
154. McCollum W.H. Pathologic features of horses given avirulent equine arteritis virus intramuscularly. Am. J. Vet. Res. 1981, 42:1218-1220.
155. McCollum W.H. Responses of horses vaccinated with avirulent modified-live equine arteritis virus propagated in the E. Derm (NBL-6) cell line to nasal inoculation with virulent virus. Am. J. Vet. Res. 1986, 47:1931-1934.
156. McCollum W.H., Bryans J.T. Serological identification of infection by equine arteritis virus in horses of several countries. Proceedings of the 3rd International Conference of Equine Infectious Diseases 1973, 256-263.
157. McCollum W.H., Little T.V., Timoney P.J., Swerczek T.W. Resistance of castrated male horses to attempted establishment of the carrier state with equine arteritis virus. J. Comp. Pathol. 1994, 111:383-388.
158. McCollum W.H., Prickett M.E., Bryans J.T. Temporal distribution of equine arteritis virus in respiratory mucosa, tissues and body fluids of horses infected by inhalation. Res. Vet. Sci. 1971, 12:459-464.
159. McCollum W.H., Timoney P.J., Tengelsen L.A. Clinical, virological and serological responses of donkeys to intranasal inoculation with the KY-84 strain of equine arteritis virus. J. Comp. Pathol. 1995, 112:207-211.
160. McCollum W.H., Timoney P.J. Experimental observations on the virulence of isolates of equine arteritis virus. Proceeding of the 8th International Conference on Equine Infectious Diseases 1998, 558-559.
161. McCollum W.H., Timoney P.J., Lee J.W., Habacker P.L., Balasuriya U.B.R., MacLachlan N.J. Features of an outbreak of equine viral arteritis on a breeding farm associated with abortion and fatal interstitial pneumonia in neonatal foals. Proceeding of the 8th International Conference on Equine Infectious Diseases 1998, 559-560.
162. McCue P.M., Hietala S.K., Spensely M.S., Mihalyi J., Hughes J.P. Prevalence of equine viral arteritis in California horses. Calif. Vet. 1991, 45:24-26.
163. McFadden A.M., Pearce P.V., Orr D., Nicoll K., Rawdon T.G., Pharo H., Stone M. Evidence for absence of equine arteritis virus in the horse population of New Zealand. N. Z. Vet. J. 2013.
164. McKenzie J. Survey of stallions for equine arteritis virus. Surveillance 1996, 17-18.
165. McKinnon A.O., Colbern G.T., Collins J.K., Bowen R.A., Voss J.L., Umphenour N.W. Vaccination of stallions with modified live equine viral arteritis virus. J. Equine Vet. Sci. 1986, 6:66-69.
166. Miszczak F., Legrand L., Balasuriya U.B., Ferry-Abitbol B., Zhang J., Hans A., Fortier G., Pronost S., Vabret A. Emergence of novel equine arteritis virus (EAV) variants during persistent infection in the stallion: origin of the 2007 French EAV outbreak was linked to an EAV strain present in the semen of a persistently infected carrier stallion. Virology 2012, 423:165-174.
167. Miszczak F., Shuck K.M., Lu Z., Go Y.Y., Zhang J., Sells S., Vabret A., Pronost S., Fortier G., Timoney P.J., Balasuriya U.B. Evaluation of two magnetic-bead-based viral nucleic acid purification kits and three real-time reverse transcription-PCR reagent systems in two TaqMan assays for equine arteritis virus detection in semen. J. Clin. Microbiol. 2011, 49:3694-3696.
168. Molenkamp R., van Tol H., Rozier B.C., van der Meer Y., Spaan W.J., Snijder E.J. The arterivirus replicase is the only viral protein required for genome replication and subgenomic mRNA transcription. J. Gen. Virol. 2000, 81:2491-2496.
169. Monastyrska I., Ulasli M., Rottier P.J., Guan J.L., Reggiori F., de Haan C.A. An autophagy-independent role for LC3 in equine arteritis virus replication. Autophagy 2013, 9:164-174.
170. Moore B.D., Balasuriya U.B., Watson J.L., Bosio C.M., MacKay R.J., MacLachlan N.J. Virulent and avirulent strains of equine arteritis virus induce different quantities of TNF-alpha and other proinflammatory cytokines in alveolar and blood-derived equine macrophages. Virology 2003, 314:662-670.
171. Moraillon A., Moraillon R. Results of an epidemiological investigation on viral arteritis in France and some other European and African countries. Ann. Rech. Vet. 1978, 9:43-54.
172. Murphy T.W., McCollum W.H., Timoney P.J., Klingeborn B.W., Hyllseth B., Golnik W., Erasmus B. Genomic variability among globally distributed isolates of equine arteritis virus. Vet. Microbiol. 1992, 32:101-115.
173. Nedialkova D.D., Gorbalenya A.E., Snijder E.J. Arterivirus Nsp1 modulates the accumulation of minus-strand templates to control the relative abundance of viral mRNAs. PLoS Pathogens 2010, 6:e1000772.
174. Nedialkova D.D., Ulferts R., van den Born E., Lauber C., Gorbalenya A.E., Ziebuhr J., Snijder E.J. Biochemical characterization of arterivirus nonstructural protein 11 reveals the nidovirus-wide conservation of a replicative endoribonuclease. J. Virol. 2009, 83:5671-5682.
175. Nitschke M., Korte T., Tielesch C., Ter-Avetisyan G., Tunnemann G., Cardoso M.C., Veit M., Herrmann A. Equine arteritis virus is delivered to an acidic compartment of host cells via clathrin-dependent endocytosis. Virology 2008, 377:248-254.
176. Nugent J., Sinclair R., deVries A.A., Eberhardt R.Y., Castillo-Olivares J., Davis Poynter N., Rottier P.J., Mumford J.A. Development and evaluation of ELISA procedures to detect antibodies against the major envelope protein (G(L)) of equine arteritis virus. J. Virol. Methods 2000, 90:167-183.
177. Pasternak A.O., Gultyaev A.P., Spaan W.J., Snijder E.J. Genetic manipulation of arterivirus alternative mRNA leader-body junction sites reveals tight regulation of structural protein expression. J. Virol. 2000, 74:11642-11653.
178. Pasternak A.O., Spaan W.J., Snijder E.J. Regulation of relative abundance of arterivirus subgenomic mRNAs. J. Virol. 2004, 78:8102-8113.
179. Pasternak A.O., Spaan W.J., Snijder E.J. Nidovirus transcription: how to make sense. . .?. J. Gen. Virol. 2006, 87:1403-1421.
180. Pasternak A.O., van den Born E., Spaan W.J., Snijder E.J. Sequence requirements for RNA strand transfer during nidovirus discontinuous subgenomic RNA synthesis. EMBO J. 2001, 20:7220-7228.
181. Pasternak A.O., van den Born E., Spaan W.J., Snijder E.J. The stability of the duplex between sense and antisense transcription-regulating sequences is a crucial factor in arterivirus subgenomic mRNA synthesis. J. Virol. 2003, 77:1175-1183.
182. Patton J.F., Balasuriya U.B., Hedges J.F., Schweidler T.M., Hullinger P.J., MacLachlan N.J. Phylogenetic characterization of a highly attenuated strain of equine arteritis virus from the semen of a persistently infected standardbred stallion. Arch. Virol. 1999, 144:817-827.
183. Pedersen K.W., van der Meer Y., Roos N., Snijder E.J. Open reading frame 1a-encoded subunits of the arterivirus replicase induce endoplasmic reticulum-derived double-membrane vesicles which carry the viral replication complex. J. Virol. 1999, 73:2016-2026.
184. Pirzadeh B., Gagnon C.A., Dea S. Genomic and antigenic variations of porcine reproductive and respiratory syndrome virus major envelope GP5 glycoprotein. Can. J. Vet. Res. 1998, 62:170-177.
185. Plagemann P.G., Moennig V. Lactate dehydrogenase-elevating virus, equine arteritis virus, and simian hemorrhagic fever virus: a new group of positive-strand RNA viruses. Adv. Virus Res. 1992, 41:99-192.
186. Pol J.M., Wagenaar F. Morphogenesis of Lelystad virus in porcine lung alveolar macrophages. American Association of Swine Practitioners Newsletter 1992, 29.
187. Pol J.M., Wagenaar F., Reus J.E.G. Comparative morphogenesis of three PRRS virus strains. Vet. Microbiol. 1997, 55:203-208.
188. Posthuma C.C., Nedialkova D.D., Zevenhoven-Dobbe J.C., Blokhuis J.H., Gorbalenya A.E., Snijder E.J. Site-directed mutagenesis of the Nidovirus replicative endoribonuclease NendoU exerts pleiotropic effects on the arterivirus life cycle. J. Virol. 2006, 80:1653-1661.
189. Posthuma C.C., Pedersen K.W., Lu Z., Joosten R.G., Roos N., Zevenhoven-Dobbe J.C., Snijder E.J. Formation of the arterivirus replication/transcription complex: a key role for nonstructural protein 3 in the remodeling of intracellular membranes. J. Virol. 2008, 82:4480-4491.
190. Pronost S., Pitel P.H., Miszczak F., Legrand L., Marcillaud-Pitel C., Hamon M., Tapprest J., Balasuriya U.B., Freymuth F., Fortier G. Description of the first recorded major occurrence of equine viral arteritis in France. Equine Vet. J. 2010, 42:713-720.
191. Radwan A.I., Burger D. The complement-requiring neutralization of equine arteritis virus by late antisera. Virology 1973, 51:71-77.
192. Ramina A., Dalla Valle L., De Mas S., Tisato E., Zuin A., Renier M., Cuteri V., Valente C., Cancellotti F.M. Detection of equine arteritis virus in semen by reverse transcriptase polymerase chain reaction-ELISA. Comp. Immunol. Microbiol. Infect. Dis. 1999, 22:187-197.
193. Rola J., Larska M., Rola J.G., Belak S., Autorino G.L. Epizotiology and phylogeny of equine arteritis virus in hucul horses. Vet. Microbiol. 2011, 148:402-407.
194. Rossow K.D. Porcine reproductive and respiratory syndrome. Vet. Pathol. 1998, 35:1-20.
195. Sawicki S.G., Sawicki D.L. Coronaviruses use discontinuous extension for synthesis of subgenome-length negative strands. Adv. Exp. Med. Biol. 1995, 380:499-506.
196. Sawicki S.G., Sawicki D.L., Siddell S.G. A contemporary view of coronavirus transcription. J. Virol. 2007, 81:20-29.
197. Sekiguchi K., Sugita S., Fukunaga Y., Kondo T., Wada R., Kamada M., Yamaguchi S. Detection of equine arteritis virus (EAV) by polymerase chain reaction (PCR) and differentiation of EAV strains by restriction enzyme analysis of PCR products. Arch. Virol. 1995, 140:1483-1491.
198. Sentsui H., Wu D., Murakami K., Kondo T., Matsumura T. Antiviral effect of recombinant equine interferon-gamma on several equine viruses. Vet. Immunol. Immunopathol. 2010, 135:93-99.
199. Seybert A., Posthuma C.C., van Dinten L.C., Snijder E.J., Gorbalenya A.E., Ziebuhr J. A complex zinc finger controls the enzymatic activities of nidovirus helicases. J. Virol. 2005, 79:696-704.
200. Seybert A., van Dinten L.C., Snijder E.J., Ziebuhr J. Biochemical characterization of the equine arteritis virus helicase suggests a close functional relationship between arterivirus and coronavirus helicases. J. Virol. 2000, 74:9586-9593.
201. Siddell S.G., Ziebuhr J., Snijder E.J. Coronaviruses, toroviruses and arteriviruses. Topley & Wilson's Microbiology and Microbial Infections, Virology 2005, 823-856. Hodder Arnold. B.W.J. Mahy, V. ter Meulen (Eds.).
202. Snijder E., Wassenaar A.L., Den Boon J.A., Spaan W.J. Proteolytic processing of the arterivirus replicase. Adv. Exp. Med. Biol. 1995, 380:443-451.
203. Snijder E.J. The arterivirus replicase. The road from RNA to protein(s), and back again. Adv. Exp. Med. Biol. 1998, 440:97-108.
204. Snijder E.J. Arterivirus RNA synthesis dissected. Nucleotides, membranes, amino acids, and a bit of zinc. Adv. Exp. Med. Biol. 2001, 494:241-253.
205. Snijder E.J., Spaan W.J.M. Arteriviruses. Fields Virology 2007, 1337-1355. Lippincott Williams & Wilkins, Philadelphia, PA. D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin, B. Roizman, S.E. Straus (Eds.).
206. Snijder E.J., Dobbe J.C., Spaan W.J. Heterodimerization of the two major envelope proteins is essential for arterivirus infectivity. J. Virol. 2003, 77:97-104.
207. Snijder E.J., Meulenberg J.J. The molecular biology of arteriviruses. J. Gen. Virol. 1998, 79:961-979.
208. Snijder E.J., Siddell S.G., Gorbalenya A.E. The order Nidovirales. Topley and Wilson's Microbiology and Microbial Infections; Virology Volume 2005, 390-404. Hodder Arnold, London. W. Mahy, V. ter Meulen (Eds.).
209. Snijder E.J., Spaan W.J. Arteriviruses. Fields Virology 2006, 1337-1355. Lippincott Williams & Wilkins, Philadelphia. D.M. Knipe, P.M. Howley (Eds.).
210. Snijder E.J., van der Meer Y., Zevenhoven-Dobbe J., Onderwater J.J., van der Meulen J., Koerten H.K., Mommaas A.M. Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex. J. Virol. 2006, 80:5927-5940.
211. Snijder E.J., van Tol H., Pedersen K.W., Raamsman M.J., de Vries A.A. Identification of a novel structural protein of arteriviruses. J. Virol. 1999, 73:6335-6345.
212. Snijder E.J., van Tol H., Roos N., Pedersen K.W. Non-structural proteins 2 and 3 interact to modify host cell membranes during the formation of the arterivirus replication complex. J. Gen. Virol. 2001, 82:985-994.
213. Snijder E.J., Wassenaar A.L., Spaan W.J. The 5' end of the equine arteritis virus replicase gene encodes a papainlike cysteine protease. J. Virol. 1992, 66:7040-7048.
214. Snijder E.J., Wassenaar A.L., Spaan W.J. Proteolytic processing of the replicase ORF1a protein of equine arteritis virus. J. Virol. 1994, 68:5755-5764.
215. Snijder E.J., Wassenaar A.L., Spaan W.J., Gorbalenya A.E. The arterivirus Nsp2 protease. An unusual cysteine protease with primary structure similarities to both papain-like and chymotrypsin-like proteases. J. Biol. Chem. 1995, 270:16671-16676.
216. Snijder E.J., Wassenaar A.L., van Dinten L.C., Spaan W.J., Gorbalenya A.E. The arterivirus nsp4 protease is the prototype of a novel group of chymotrypsin-like enzymes, the 3C-like serine proteases. J. Biol. Chem. 1996, 271:4864-4871.
217. Spilman M.S., Welbon C., Nelson E., Dokland T. Cryo-electron tomography of porcine reproductive and respiratory syndrome virus: organization of the nucleocapsid. J. Gen. Virol. 2009, 90:527-535.
218. St-Laurent G., Morin G., Archambault D. Detection of equine arteritis virus following amplification of structural and nonstructural viral genes by reverse transcription-PCR. J. Clin. Microbiol. 1994, 32:658-665.
219. St-Louis M.C., Archambault D. The equine arteritis virus induces apoptosis via caspase-8 and mitochondria-dependent caspase-9 activation. Virology 2007, 367:147-155.
220. Stadejek T., Bjorklund H., Bascunana C.R., Ciabatti I.M., Scicluna M.T., Amaddeo D., McCollum W.H., Autorino G.L., Timoney P.J., Paton D.J., Klingeborn B., Belak S. Genetic diversity of equine arteritis virus. J. Gen. Virol. 1999, 80(Pt 3):691-699.
221. Stadejek T., Mittelholzer C., Oleksiewicz M.B., Paweska J., Belak S. Highly diverse type of equine arteritis virus (EAV) from the semen of a South African donkey: short communication. Acta Vet. Hung. 2006, 54:263-270.
222. Starik E., Ginter A., Coppe P. ELISA and direct immunofluorescence test to detect equine arteritis virus (EAV) using a monoclonal antibody directed to the EAV-N protein. J. Vet. Med. B Infect. Dis. Vet. Public Health 2001, 48:1-9.
223. Stein D., Foster E., Huang S.B., Weller D., Summerton J. A specificity comparison of four antisense types: morpholino, 2'-O-methyl RNA, DNA, and phosphorothioate DNA. Antisense Nucleic Acid Drug Dev. 1997, 7:151-157.
224. Stertz S., Reichelt M., Spiegel M., Kuri T., Martinez-Sobrido L., Garcia-Sastre A., Weber F., Kochs G. The intracellular sites of early replication and budding of SARS-coronavirus. Virology 2007, 361:304-315.
225. Stueckemann J.A., Holth M., Swart W.J., Kowalchyk K., Smith M.S., Wolstenholme A.J., Cafruny W.A., Plagemann P.G. Replication of lactate dehydrogenase-elevating virus in macrophages. 2. Mechanism of persistent infection in mice and cell culture. J. Gen. Virol. 1982, 59:263-272.
226. Subramaniam S., Kwon B., Beura L.K., Kuszynski C.A., Pattnaik A.K., Osorio F.A. Porcine reproductive and respiratory syndrome virus non-structural protein 1 suppresses tumor necrosis factor-alpha promoter activation by inhibiting NF-kappaB and Sp1. Virology 2010, 406:270-279.
227. Summerton J. Morpholino antisense oligomers: the case for an RNase H-independent structural type. Biochim. Biophys. Acta 1999, 1489:141-158.
228. Summerton J., Weller D. Morpholino antisense oligomers: design, preparation, and properties. Antisense Nucleic Acid Drug Dev. 1997, 7:187-195.
229. Sun Z., Li Y., Ransburgh R., Snijder E.J., Fang Y. Nonstructural protein 2 of porcine reproductive and respiratory syndrome virus inhibits the antiviral function of interferon-stimulated gene 15. J. Virol. 2012, 86:3839-3850.
230. Surma-Kurusiewicz K., Winiarczyk S., Adaszek L. Comparative analysis of ORF5 nucleotide sequences and amino acid sequences of the GP5 protein of equine arteritis virus (EAV) detected in the semen of stallions from Eastern Poland. Res. Vet. Sci. 2012.
231. Swinburne J. Inherited disease in the horse: mapping complex disease variants is on the horizon. Vet. J. 2009, 179:317-318.
232. Szeredi L., Hornyak A., Denes B., Rusvai M. Equine viral arteritis in a newborn foal: parallel detection of the virus by immunohistochemistry, polymerase chain reaction and virus isolation. J. Vet. Med. B Infect. Dis. Vet. Public Health 2003, 50:270-274.
233. Szeredi L., Hornyak A., Palfi V., Molnar T., Glavits R., Denes B. Study on the epidemiology of equine arteritis virus infection with different diagnostic techniques by investigating 96 cases of equine abortion in Hungary. Vet. Microbiol. 2005, 108:235-242.
234. te Velthuis A.J., van den Worm S.H., Sims A.C., Baric R.S., Snijder E.J., van Hemert M.J. Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathogens 2010, 6:e1001176.
235. Thaa B., Kabatek A., Zevenhoven-Dobbe J.C., Snijder E.J., Herrmann A., Veit M. Myristoylation of the arterivirus E protein: the fatty acid modification is not essential for membrane association but contributes significantly to virus infectivity. J. Gen. Virol. 2009, 90:2704-2712.
236. Tian D., Wei Z., Zevenhoven-Dobbe J.C., Liu R., Tong G., Snijder E.J., Yuan S. Arterivirus minor envelope proteins are a major determinant of viral tropism in cell culture. J. Virol. 2012, 86:3701-3712.
237. Tijms M.A., Nedialkova D.D., Zevenhoven-Dobbe J.C., Gorbalenya A.E., Snijder E.J. Arterivirus subgenomic mRNA synthesis and virion biogenesis depend on the multifunctional nsp1 autoprotease. J. Virol. 2007, 81:10496-10505.
238. Tijms M.A., Snijder E.J. Equine arteritis virus non-structural protein 1, an essential factor for viral subgenomic mRNA synthesis, interacts with the cellular transcription co-factor p100. J. Gen. Virol. 2003, 84:2317-2322.
239. Tijms M.A., van der Meer Y., Snijder E.J. Nuclear localization of non-structural protein 1 and nucleocapsid protein of equine arteritis virus. J. Gen. Virol. 2002, 83:795-800.
240. Tijms M.A., van Dinten L.C., Gorbalenya A.E., Snijder E.J. A zinc finger-containing papain-like protease couples subgenomic mRNA synthesis to genome translation in a positive-stranded RNA virus. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:1889-1894.
241. Timoney P.J. Equine viral arteritis: epidemiology and control. J. Equine Vet. Sci. 1988, 8:54-59.
242. Timoney P.J., McCollum W.H. Equine viral arteritis: epidemiology and control. J. Equine Vet. Sci. 1988, 8:54-59.
243. Timoney P.J., McCollum W.H. Equine viral arteritis. Vet. Clin. North Am. Equine Pract. 1993, 9:295-309.
244. Timoney P.J., McCollum W.H., Murphy T.W., Roberts A.W., Willard J.G., Carswell G.D. The carrier state in equine arteritis virus infection in the stallion with specific emphasis on the venereal mode of virus transmission. J. Reprod. Fertil. Suppl. 1987, 35:95-102.
245. Timoney P.J., McCollum W.H., Roberts A.W., Murphy T.W. Demonstration of the carrier state in naturally acquired equine arteritis virus infection in the stallion. Res. Vet. Sci. 1986, 41:279-280.
246. Timoney P.J., Umphenour N.W., McCollum W.H. Safety evaluation of a commercial modified live equine arteritis virus vaccine for use in stallions. Proceedings of the fifth International Conference on Equine Infectious Diseases 1988, 19-27. D.G. Powell (Ed.).
247. Tobiasch E., Kehm R., Bahr U., Tidona C.A., Jakob N.J., Handermann M., Darai G., Giese M. Large envelope glycoprotein and nucleocapsid protein of equine arteritis virus (EAV) induce an immune response in Balb/c mice by DNA vaccination; strategy for developing a DNA-vaccine against EAV-infection. Virus Genes 2001, 22:187-199.
248. Vaala W.E., Hamir A.N., Dubovi E.J., Timoney P.J., Ruiz B. Fatal, congenitally acquired infection with equine arteritis virus in a neonatal thoroughbred. Equine Vet. J. 1992, 24:155-158.
249. Vairo S., Vandekerckhove A., Steukers L., Glorieux S., Van den Broeck W., Nauwynck H. Clinical and virological outcome of an infection with the Belgian equine arteritis virus strain 08P178. Vet. Microbiol. 2012, 157:12.
250. van Aken D., Benckhuijsen W.E., Drijfhout J.W., Wassenaar A.L., Gorbalenya A.E., Snijder E.J. Expression, purification, and in vitro activity of an arterivirus main proteinase. Virus Res. 2006, 120:97-106.
251. van Aken D., Snijder E.J., Gorbalenya A.E. Mutagenesis analysis of the nsp4 main proteinase reveals determinants of arterivirus replicase polyprotein autoprocessing. J. Virol. 2006, 80:3428-3437.
252. van Aken D., Zevenhoven-Dobbe J., Gorbalenya A.E., Snijder E.J. Proteolytic maturation of replicase polyprotein pp1a by the nsp4 main proteinase is essential for equine arteritis virus replication and includes internal cleavage of nsp7. J. Gen. Virol. 2006, 87:3473-3482.
253. van den Born E., Posthuma C.C., Gultyaev A.P., Snijder E.J. Discontinuous subgenomic RNA synthesis in arteriviruses is guided by an RNA hairpin structure located in the genomic leader region. J. Virol. 2005, 79:6312-6324.
254. van den Born E., Posthuma C.C., Knoops K., Snijder E.J. An infectious recombinant equine arteritis virus expressing green fluorescent protein from its replicase gene. J. Gen. Virol. 2007, 88:1196-1205.
255. van den Born E., Stein D.A., Iversen P.L., Snijder E.J. Antiviral activity of morpholino oligomers designed to block various aspects of Equine arteritis virus amplification in cell culture. J. Gen. Virol. 2005, 86:3081-3090.
256. van der Meer F.J., de Haan C.A., Schuurman N.M., Haijema B.J., Peumans W.J., Van Damme E.J., Delputte P.L., Balzarini J., Egberink H.F. Antiviral activity of carbohydrate-binding agents against Nidovirales in cell culture. Antiviral Res. 2007, 76:21-29.
257. van der Meer Y., Snijder E.J., Dobbe J.C., Schleich S., Denison M.R., Spaan W.J., Locker J.K. Localization of mouse hepatitis virus nonstructural proteins and RNA synthesis indicates a role for late endosomes in viral replication. J. Virol. 1999, 73:7641-7657.
258. van der Meer Y., van Tol H., Locker J.K., Snijder E.J. ORF1a-encoded replicase subunits are involved in the membrane association of the arterivirus replication complex. J. Virol. 1998, 72:6689-6698.
259. van Dinten L.C., den Boon J.A., Wassenaar A.L., Spaan W.J., Snijder E.J. An infectious arterivirus cDNA clone: identification of a replicase point mutation that abolishes discontinuous mRNA transcription. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:991-996.
260. van Dinten L.C., Rensen S., Gorbalenya A.E., Snijder E.J. Proteolytic processing of the open reading frame 1b-encoded part of arterivirus replicase is mediated by nsp4 serine protease and is essential for virus replication. J. Virol. 1999, 73:2027-2037.
261. van Dinten L.C., van Tol H., Gorbalenya A.E., Snijder E.J. The predicted metal-binding region of the arterivirus helicase protein is involved in subgenomic mRNA synthesis, genome replication, and virion biogenesis. J. Virol. 2000, 74:5213-5223.
262. van Dinten L.C., Wassenaar A.L., Gorbalenya A.E., Spaan W.J., Snijder E.J. Processing of the equine arteritis virus replicase ORF1b protein: identification of cleavage products containing the putative viral polymerase and helicase domains. J. Virol. 1996, 70:6625-6633.
263. van Hemert M.J., de Wilde A.H., Gorbalenya A.E., Snijder E.J. The in vitro RNA synthesizing activity of the isolated arterivirus replication/transcription complex is dependent on a host factor. J. Biol. Chem. 2008, 283:16525-16536.
264. Van Hemert M.J., Snijder E.J. The arterivirus replicase. Nidoviruses 2008, 83-101. American Society for Microbiology, Washington, DC. S. Perlman, T. Gallagher, E.J. Snijder (Eds.).
265. van Kasteren P.B., Bailey-Elkin B.A., James T.W., Ninaber D.K., Beugeling C., Khajehpour M., Snijder E.J., Mark B.L., Kikkert M. Deubiquitinase function of arterivirus papain-like protease 2 suppresses the innate immune response in infected host cells. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:E838-E847.
266. van Kasteren P.B., Beugeling C., Ninaber D.K., Frias-Staheli N., van Boheemen S., Garcia-Sastre A., Snijder E.J., Kikkert M. Arterivirus and nairovirus ovarian tumor domain-containing deubiquitinases target activated RIG-I to control innate immune signaling. J. Virol. 2012, 86:773-785.
267. van Marle G., Dobbe J.C., Gultyaev A.P., Luytjes W., Spaan W.J., Snijder E.J. Arterivirus discontinuous mRNA transcription is guided by base pairing between sense and antisense transcription-regulating sequences. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:12056-12061.
268. van Marle G., van Dinten L.C., Spaan W.J., Luytjes W., Snijder E.J. Characterization of an equine arteritis virus replicase mutant defective in subgenomic mRNA synthesis. J. Virol. 1999, 73:5274-5281.
269. Verheije M.H., Welting T.J., Jansen H.T., Rottier P.J., Meulenberg J.J. Chimeric arteriviruses generated by swapping of the M protein ectodomain rule out a role of this domain in viral targeting. Virology 2002, 303:364-373.
270. Wade C.M., Giulotto E., Sigurdsson S., Zoli M., Gnerre S., Imsland F., Lear T.L., Adelson D.L., Bailey E., Bellone R.R., Blocker H., Distl O., Edgar R.C., Garber M., Leeb T., Mauceli E., MacLeod J.N., Penedo M.C., Raison J.M., Sharpe T., Vogel J., Andersson L., Antczak D.F., Biagi T., Binns M.M., Chowdhary B.P., Coleman S.J., Della Valle G., Fryc S., Guerin G., Hasegawa T., Hill E.W., Jurka J., Kiialainen A., Lindgren G., Liu J., Magnani E., Mickelson J.R., Murray J., Nergadze S.G., Onofrio R., Pedroni S., Piras M.F., Raudsepp T., Rocchi M., Roed K.H., Ryder O.A., Searle S., Skow L., Swinburne J.E., Syvanen A.C., Tozaki T., Valberg S.J., Vaudin M., White J.R., Zody M.C., Lander E.S., Lindblad-Toh K. Genome sequence, comparative analysis, and population genetics of the domestic horse. Science (New York, NY) 2009, 326:865-867.
271. Wagner H.M., Balasuriya U.B., James MacLachlan N. The serologic response of horses to equine arteritis virus as determined by competitive enzyme-linked immunosorbent assays (c-ELISAs) to structural and non-structural viral proteins. Comp. Immunol. Microbiol. Infect. Dis. 2003, 26:251-260.
272. Wassenaar A.L., Spaan W.J., Gorbalenya A.E., Snijder E.J. Alternative proteolytic processing of the arterivirus replicase ORF1a polyprotein: evidence that NSP2 acts as a cofactor for the NSP4 serine protease. J. Virol. 1997, 71:9313-9322.
273. Weiland E., Bolz S., Weiland F., Herbst W., Raamsman M.J., Rottier P.J., De Vries A.A. Monoclonal antibodies directed against conserved epitopes on the nucleocapsid protein and the major envelope glycoprotein of equine arteritis virus. J. Clin. Microbiol. 2000, 38:2065-2075.
274. Westcott D.G., King D.P., Drew T.W., Nowotny N., Kindermann J., Hannant D., Belak S., Paton D.J. Use of an internal standard in a closed one-tube RT-PCR for the detection of equine arteritis virus RNA with fluorescent probes. Vet. Res. 2003, 34:165-176.
275. Wieringa R., De Vries A.A., Post S.M., Rottier P.J. Intra- and intermolecular disulfide bonds of the GP2b glycoprotein of equine arteritis virus: relevance for virus assembly and infectivity. J. Virol. 2003, 77:12996-13004.
276. Wieringa R., de Vries A.A., Raamsman M.J., Rottier P.J. Characterization of two new structural glycoproteins, GP(3) and GP(4), of equine arteritis virus. J. Virol. 2002, 76:10829-10840.
277. Wieringa R., de Vries A.A., Rottier P.J. Formation of disulfide-linked complexes between the three minor envelope glycoproteins (GP2b, GP3, and GP4) of equine arteritis virus. J. Virol. 2003, 77:6216-6226.
278. Wieringa R., de Vries A.A., van der Meulen J., Godeke G.J., Onderwater J.J., van Tol H., Koerten H.K., Mommaas A.M., Snijder E.J., Rottier P.J. Structural protein requirements in equine arteritis virus assembly. J. Virol. 2004, 78:13019-13027.
279. Wood O., Tauraso N., Liebhaber H. Electron microscopic study of tissue cultures infected with simian haemorrhagic fever virus. J. Gen. Virol. 1970, 7:129-136.
280. Wu W.H., Fang Y., Rowland R.R., Lawson S.R., Christopher-Hennings J., Yoon K.J., Nelson E.A. The 2b protein as a minor structural component of PRRSV. Virus Res. 2005, 114:177-181.
281. Zevenhoven-Dobbe J.C., Greve S., van Tol H., Spaan W.J., Snijder E.J. Rescue of disabled infectious single-cycle (DISC) equine arteritis virus by using complementing cell lines that express minor structural glycoproteins. J. Gen. Virol. 2004, 85:3709-3714.
282. Zhang J., Go Y.Y., Huang C.M., Meade B.J., Lu Z., Snijder E.J., Timoney P.J., Balasuriya U.B. Development and characterization of an infectious cDNA clone of the modified live virus vaccine strain of equine arteritis virus. Clin. Vaccine Immunol. 2012, 19:1312-1321.
283. Zhang J., Go Y.Y., MacLachlan N.J., Meade B.J., Timoney P.J., Balasuriya U.B. Amino acid substitutions in the structural or nonstructural proteins of a vaccine strain of equine arteritis virus are associated with its attenuation. Virology 2008, 378:355-362.
284. Zhang J., Stein D.A., Timoney P.J., Balasuriya U.B. Curing of HeLa cells persistently infected with equine arteritis virus by a peptide-conjugated morpholino oligomer. Virus Res. 2010, 150:138-142.
285. Zhang J., Timoney P.J., MacLachlan N.J., McCollum W.H., Balasuriya U.B. Persistent equine arteritis virus infection in HeLa cells. J. Virol. 2008, 82:8456-8464.
286. Zhang J., Timoney P.J., Shuck K.M., Seoul G., Go Y.Y., Lu Z., Powell D.G., Meade B.J., Balasuriya U.B. Molecular epidemiology and genetic characterization of equine arteritis virus isolates associated with the 2006-2007 multi-state disease occurrence in the USA. J. Gen. Virol. 2010, 91:2286-2301.
287. Zhang J., Timoney P.J., MacLachlan N.J., Balasuriya U.B.R. Identification of an additional neutralization determinant of equine arteritis virus. Virus Res. 2008, 138(1-2):4.
288. Ziebuhr J., Snijder E.J., Gorbalenya A.E. Virus-encoded proteinases and proteolytic processing in the Nidovirales. J. Gen. Virol. 2000, 81:853-879.